Cardinal Health Q3 2024 Adj EPS $2.08 Beats $1.95 Estimate, Sales $54.911B Miss $56.054B Estimate
Portfolio Pulse from Benzinga Newsdesk
Cardinal Health reported Q3 2024 adjusted EPS of $2.08, surpassing the $1.95 estimate, marking a 19.54% year-over-year increase. However, their sales of $54.911B fell short of the $56.054B estimate, despite being an 8.76% increase from the previous year.
May 02, 2024 | 10:47 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Cardinal Health's Q3 2024 earnings surpassed estimates with an EPS of $2.08, indicating a 19.54% increase from last year, but sales missed expectations.
The positive earnings surprise could lead to short-term positive sentiment, offset by the missed sales estimates. The mixed results present a neutral outlook, as the earnings beat may boost investor confidence, while the sales miss could raise concerns about growth prospects.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100